SINTX signs supply agreement with Evonik for SiN/PEEK compound for 3D-printed implants

Sintx Technologies, Inc.

Evonik Corporation will manufacture SINTX's proprietary SiN/PEEK compound (U.S. Patent No. 10,806,831) at commercial scale.
Enables immediate production of AI-assisted, 3D-printed patient-specific implants for humanitarian-use vertebral body replacement (VBR) cases.
SINTX has received physician requests for VBR implants for orthopedic and neurosurgical oncology patients post-tumor resection.
SiN/PEEK offers antipathogenic surface behavior, osteogenic support, and improved visualization vs. standard PEEK.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.